Select Filters
Apply Filters
Reset Filters

Biomarker & Neural System Effects of Calcineurin Inhibition with Tacrolimus

Steven Arnold, M.D.
Charlestown, MA - United States
2020

Modulation of Hippocampal Cicuitry with Focused Ultrasound in MCI

Susan Bookheimer, Ph.D.
Los Angeles, CA - United States
2020

The Role of Parthanatos in Alzheimer's Disease

Ted Dawson, M.D., Ph.D.
Baltimore, MD - United States
2020

Evaluating oral semaglutide as a treatment for Alzheimer's disease

Paul Edison, M.B.B.S, F.R.C.P., Ph.D.
London, United Kingdom
2020

ALSENLITE: An Open-Label Pilot Study Of Senolytics For Alzheimer Disease

James Kirkland, M.D., Ph.D.
Rochester, MN - United States
2020

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of Alzheimer's Disease

John Sedivy, Ph.D.
Providence, RI - United States
2020

ENIGMA-APOE2 : A global Study of the Alzheimer's Protective Genotype

Paul Thompson, Ph.D.
Los Angeles, CA - United States
2020

SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer’s Disease

Maurice Zauderer, Ph.D.
Rochester, NY - United States
2020

AD Pathology and Perioperative Neurocognitive Disorders

Mary Ackenbom, M.D.
Pittsburgh, PA - United States
2019

Understanding the Impact of a Late-Onset Alzheimer's Disease Mutation in CD2AP on Synapses

Claudia Almeida, Ph.D.
Lisbon, Portugal
2019

Burden and correlates of cognitive performance in Syrian refugees in Jordan

Tala Al-Rousan, MD
San Diego, CA - United States
2019

Brain vulnerability and resilience during midlife

Eider Arenaza-Urquijo, Ph.D.
Barcelona, Spain
2019

Postoperative delirium and cognitive outcomes in older adults with and without ADRD: Relationship with baseline characteristics, diversity, and caregiver factors

Franchesca Arias, Ph.D.
Boston, MA - United States
2019

Assessment of Cognitive Effort in Alzheimer Disease

Andrew Aschenbrenner, Ph.D.
St. Louis, MO - United States
2019

Hypothalamic dysfunction as a driver of age-related cognitive decline

Ahmad Aziz, M.D., Ph.D.
Bonn, Germany
2019

Glial Control of the Local Neuronal Translatome in Alzheimer's Disease

Jimena Baleriola Gomez De Pablos, Ph.D.
Leioa, Spain
2019

Systemic Inflammation as a Factor to Influence Alzheimer’s Disease

Tatiana Barichello, Ph.D.
Houston, TX - United States
2019

Unravelling a novel mechanism favoring brain insulin resistance development

Eugenio Barone, Ph.D.
Rome, Italy
2019

Multimodal Intergenerational Social Contact Intervention (MISCI)

Phaedra Bell, PhD
San Francisco, CA - United States
2019

AD Biomarker and Risk Characterization in Cognitively Unimpaired Middle-Age

Tobey Betthauser, Ph.D.
Madison, WI - United States
2019

Examination of pS129-a-synuclein as a biomarker in brain-derived exosomes

Gal Bitan, Ph.D.
Los Angeles, CA - United States
2019

Cognitive Behavioral Therapy for Insomnia for Dyads Living with Dementia

Glenna Brewster, Ph.D.
Atlanta, GA - United States
2019

Cortical Excitability as a Disease Marker in early Alzheimer’s Disease

Stephanie Buss, M.D.
Boston, MA - United States
2019

Identification of drug-disease Interaction in AD patients from GAAIN

Feng Cheng, Ph.D.
Tampa, FL - United States
2019

Tau and alpha-synuclein oligomers: Cognitive predictors in synucleinopathy

Alice Chen-Plotkin, M.D.
Philadelphia, PA - United States
2019

Live Cell Imaging Reagents of Tau Modifications

Yongku Cho, Ph.D.
Storrs, CT - United States
2019

Astrocytes as a New Cellular Player in Tau-Induced Neurotoxicity in Alzheimer's Disease

Pablo Cisternas, Ph.D.
Bloomington, IN - United States
2019

Course Trajectories and Associated Factors in Alzheimer's Disease

Carl Cohen, M.D.
Brooklyn, NY - United States
2019

Nup153 as target to improve neurogenesis and cognitive function in AD

Claudia Colussi, Ph.D.
Rome, Italy
2019

Stratification of AD and FTLD using the ATN system and Cognitive Markers

Katheryn Cousins, Ph.D.
Philadelphia, PA - United States
2019

1 2 3 4 5 6 7 8 9 10... >|